PLoS Computational Biology · 2017 · 101 citations · 12 references
PharmacyBioinformaticsOncologyComputational BiologyDrug DiscoveryMolecular OncologyCombination Cancer TherapyComputational Drug DiscoveryComputational OncologyHigh-throughput ScreeningPersonalized Cancer TherapyVirtual ScreeningComputational ScreeningDrug Combination PredictionDrug Combination Synergy PredictionDrug Combination TherapyDrug Synergy ModelingDrug Synergy PredictionSynergistic Drug CombinationsTherapeutic Synergy Prediction
A promising alternative to address the problem of acquired drug resistance is to rely on combination therapies. Identification of the right combinations is often accomplished through trial and error, a labor and resource intensive process whose scale quickly escalates as more drugs can be combined. To address this problem, we present a broad computational approach for predicting synergistic combinations using easily obtainable single drug efficacy, no detailed mechanistic understanding of drug function, and limited drug combination testing. When applied to mutant BRAF melanoma, we found that our approach exhibited significant predictive power. Additionally, we validated previously untested synergy predictions involving anticancer molecules. As additional large combinatorial screens become available, this methodology could prove to be impactful for identification of drug synergy in context of other types of cancers.
12
Leo Breiman · Machine Learning · 2001 · 126.2K citations · Full text
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
Paul B. Chapman, Axel Hauschild, Caroline Robert et al. · New England Journal of Medicine · 2011 · 7.7K citations · Full text
Distinct Sets of Genetic Alterations in Melanoma
John A. Curtin, Jane Fridlyand, Toshiro Kageshita et al. · New England Journal of Medicine · 2005 · 2.7K citations · Full text